Biosimilars
- Etanercept (BENEPALI)
-
Infliximab (FLIXABI)
-
Study proposals are currently being considered for support when related to:
- Adult rheumatoid arthritis
- Adult psoriatic arthritis
- Adult axial spondyloarthritis, including ankylosing spondylitis and non-radiographic spondyloarthritis
- Adult plaque psoriasis
- Adult and paediatric Crohn’s disease
- Adult and paediatric ulcerative colitis
Established areas of research include:
- Immunogenicity
- Maintenance of response
- Prediction and optimization of response
- Treatment modalities
- Patient reported outcomes
- Patient satisfaction
- Healthcare resource utilisation
Please note that ONLY proposals from within the EU will be considered by Biogen.
Research support is awarded on a highly competitive basis, and submission of research proposals in these areas of interest does not guarantee that support will be awarded.
-